MPM BioImpact’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-443,702
| Closed | -$6.4M | – | 43 |
|
|
2022
Q3 | $6.4M | Hold |
443,702
| – | – | 1.52% | 18 |
|
|
2022
Q2 | $6.71M | Hold |
443,702
| – | – | 1.86% | 15 |
|
|
2022
Q1 | $5.27M | Sell |
443,702
-2,755
| -0.6% | -$32.7K | 1.41% | 19 |
|
|
2021
Q4 | $7.24M | Sell |
446,457
-6,513
| -1% | -$106K | 1.32% | 19 |
|
|
2021
Q3 | $12.9M | Buy |
452,970
+115,679
| +34% | +$3.3M | 2.01% | 13 |
|
|
2021
Q2 | $11.4M | Hold |
337,291
| – | – | 1.87% | 13 |
|
|
2021
Q1 | $10.2M | Hold |
337,291
| – | – | 1.28% | 12 |
|
|
2020
Q4 | $16.7M | Hold |
337,291
| – | – | 2.93% | 11 |
|
|
2020
Q3 | $12.9M | Hold |
337,291
| – | – | 3.12% | 10 |
|
|
2020
Q2 | $14.6M | Hold |
337,291
| – | – | 3.87% | 9 |
|
|
2020
Q1 | $8.8M | Hold |
337,291
| – | – | 5.38% | 7 |
|
|
2019
Q4 | $10.5M | Buy |
+337,291
| New | +$10.5M | 3.74% | 9 |
|